Trials / Completed
CompletedNCT03161886
A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).
A Treat-to-target Strategy Using Pan-enterica Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Azienda Policlinico Umberto I · Academic / Other
- Sex
- All
- Age
- 6 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, interventional study aims this to determine the efficacy and safety of a PCE-based treat-to-target strategy in order to achieve Mucosal Healing (MH) and deep remission (DR) of pediatric Crohn's Disease (CD) over 52 weeks.
Detailed description
This first prospective study on mucosal healing (MH) and deep remission (DR) in pediatric Crohn's Disease aims to evaluate: * The ability of Pan-enteric capsule endoscopy (PCE) to assess MH and DR rates at three time points and to guide a treat-to-target strategy was the primary outcome sought. * The efficacy of a "treat-to-target" strategy to MH and DR rates over 24 and 52 weeks was evaluated as a secondary outcome; * Comparison between PCE, biomarkers, Magnetic Resonance Enterography (MRE) and Small Intestine contrast ultrasonography (SICUS) in evaluating intestinal inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pan-enteric Capsule Endoscopy (PCE) | Second generation of colon capsule endoscopy (Medtronic) |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2016-12-01
- Completion
- 2017-01-10
- First posted
- 2017-05-22
- Last updated
- 2018-01-08
Source: ClinicalTrials.gov record NCT03161886. Inclusion in this directory is not an endorsement.